Cargando…

CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche

Cancer stem cells (CSCs) are an attractive therapeutic target due to their predicted role in both metastasis and chemoresistance. One of the most commonly agreed on markers for ovarian CSCs is the cell surface protein CD133. CD133+ ovarian CSCs have increased tumorigenicity, resistance to chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Lynn, Bobbs, Alexander, Sattler, Rachel, Kurkewich, Jeffrey L, Dausinas, Paige B, Nallathamby, Prakash, Cowden Dahl, Karen D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894897/ https://www.ncbi.nlm.nih.gov/pubmed/29662326 http://dx.doi.org/10.1177/1179064418767882

Ejemplares similares

ARID3B Directly Regulates Ovarian Cancer Promoting Genes
por: Bobbs, Alexander, et al.
Publicado: (2015)

Emerging and Evolving Ovarian Cancer Animal Models
por: Bobbs, Alexander S, et al.
Publicado: (2015)

Arid3b Is Critical for B Lymphocyte Development
por: Kurkewich, Jeffrey L., et al.
Publicado: (2016)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
por: Roy, Lynn, et al.
Publicado: (2018)

CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)

CD133 Act as an Essential Marker in Ovarian Carcinogenesis
por: Ikram, Dzul, et al.
Publicado: (2021)

Regulation of Osteosclerosis by Inoculated Cd133(+) PC3 Cells in Bone‐marrow Microenvironmental Niches
por: Kim, Donghwi, et al.
Publicado: (2019)

The role of CD133 in cancer: a concise review
por: Glumac, Paige M., et al.
Publicado: (2018)

ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature
por: Roy, Lynn, et al.
Publicado: (2014)

Exosomes promote pre-metastatic niche formation in ovarian cancer
por: Feng, Wenlong, et al.
Publicado: (2019)

The effects of DNA methylation and epigenetic factors on the expression of CD133 in ovarian cancers
por: Min, Kyung-Jin, et al.
Publicado: (2012)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

3058 – SARS-COV-2 BINDING IN HEMATOPOIETIC STEM AND PROGENITOR CELLS UNDER LOW OXYGEN CONDITIONS
por: Dausinas, Paige, et al.
Publicado: (2021)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

CD133 Targeted PVP/PMMA Microparticle Incorporating Levamisole for the Treatment of Ovarian Cancer
por: Wang, Yu-Chi, et al.
Publicado: (2020)

MAPK Signaling Is Required for Generation of Tunneling Nanotube-Like Structures in Ovarian Cancer Cells
por: Cole, Jennifer M., et al.
Publicado: (2021)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Response to Stress in Early Tumor Colonization Modulates Switching of CD133-Positive and CD133-Negative Subpopulations in a Human Metastatic Colon Cancer Cell Line, SW620
por: Hsu, Chih-Sin, et al.
Publicado: (2013)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma
por: Liu, Chao Lien, et al.
Publicado: (2020)

Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer
por: Brocco, Davide, et al.
Publicado: (2022)

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer
por: Cioffi, Michele, et al.
Publicado: (2015)

Autocrine interleukin-23 promotes self-renewal of CD133(+) ovarian cancer stem-like cells
por: Wang, Dan, et al.
Publicado: (2016)

Combined Serum DKK3 and Circulating CD133 Cells as Prognostic Biomarkers for Ovarian Cancer Patients
por: Nie, Xiao-Cui, et al.
Publicado: (2021)

CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016)

CD133 in brain tumor: the prognostic factor
por: Li, Bin, et al.
Publicado: (2016)

THE CD133-POSITIVE COLON CANCER CELL PHENOTYPE IS MORE INTERACTIVE WITH THE TUMOR MICROENVIRONMENT COMPARED TO CD133-NEGATIVE CELL
por: Chao, Celia, et al.
Publicado: (2011)

基因芯片筛选CD133(+)/CD133(-)肺腺癌细胞中新的耐药基因
Publicado: (2014)

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies
por: Cervantes-Madrid, Diana, et al.
Publicado: (2017)

The metastatic niche and stromal progression
por: Sleeman, Jonathan P.
Publicado: (2012)

Engineering the pre-metastatic niche
por: Aguado, Brian A., et al.
Publicado: (2017)

The Hepatic Pre-Metastatic Niche
por: Ormseth, Benjamin, et al.
Publicado: (2022)

CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012)

Epithelial-mesenchymal transition and metastatic ability of CD133(+) colorectal cancer stem-like cells under hypoxia
por: Okada, Masamichi, et al.
Publicado: (2021)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l3r9bb1gkmi36lcuee2ss2v518